One way to reconcile the opposing effects of SIRT1 on the proliferation of different cells is that certain proliferative tissues including RA-FLS and a subset of cancers may share common SIRT1-dependent signaling pathways distinct from those in other cell types. The gene discussed is SIRT1; the disease is cancer.